Natriuretic Peptide Receptor-C Protects Against Angiotensin II-Mediated Sinoatrial Node Disease in Mice

Martin Mackasey; Emmanuel E. Egom; Hailey J. Jansen; Rui Hua; Motahareh Moghtadaei; Yingjie Liu; Jaspreet Kaur; Megan D. McRae; Oleg Bogachev; Sara A. Rafferty; Gibanananda Ray; Adam W. Kirkby; Robert A. Rose

doi:10.1016/j.jacbts.2018.08.004

Natriuretic Peptide Receptor-C Protects Against Angiotensin II-Mediated Sinoatrial Node Disease in Mice

Martin Mackasey, Emmanuel E. Egom, Hailey J. Jansen, Rui Hua, Motahareh Moghtadaei, Yingjie Liu, Jaspreet Kaur, Megan D. McRae, Oleg Bogachev, Sara A. Rafferty, Gibanananda Ray, Adam W. Kirkby, Robert A. Rose

Medicine

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

30 Citas (Scopus)

Resumen

Sinoatrial node (SAN) disease mechanisms are poorly understood, and therapeutic options are limited. Natriuretic peptide(s) (NP) are cardioprotective hormones whose effects can be mediated partly by the NP receptor C (NPR-C). We investigated the role of NPR-C in angiotensin II (Ang II)-mediated SAN disease in mice. Ang II caused SAN disease due to impaired electrical activity in SAN myocytes and increased SAN fibrosis. Strikingly, Ang II treatment in NPR-C ^−/− mice worsened SAN disease, whereas co-treatment of wild-type mice with Ang II and a selective NPR-C agonist (cANF) prevented SAN dysfunction. NPR-C may represent a new target to protect against the development of Ang II-induced SAN disease.

Idioma original	English
Páginas (desde-hasta)	824-843
Número de páginas	20
Publicación	JACC: Basic to Translational Science
Volumen	3
N.º	6
DOI	https://doi.org/10.1016/j.jacbts.2018.08.004
Estado	Published - dic. 2018

Nota bibliográfica

Funding Information:
Supported by Canadian Institutes of Health Research grants MOP 93718 and 142486 to Prof. Rose. Prof. Rose holds a New Investigator Award from the Heart and Stroke Foundation of Canada. Dr. Egom is an employee of ECTRS Ltd. Mr. Mackasey is the recipient of a Libin Cardiovascular Institute of Alberta graduate scholarship. Dr. Egom held a Heart and Stroke Foundation of Canada fellowship. Dr. Jansen holds a Killam postdoctoral fellowship. Dr. Liu is the recipient of a Cumming School of Medicine postdoctoral scholarship. The other authors have reported that they have no industry relationships relevant to the contents of this paper to disclose. Dr. Egom is currently affiliated with the Department of Medicine, St. Martha’s Regional Hospital, Antigonish, Nova Scotia, Canada.

Publisher Copyright:
© 2018 The Authors

ASJC Scopus Subject Areas

Cardiology and Cardiovascular Medicine

Acceder al documento

10.1016/j.jacbts.2018.08.004

Otros archivos y enlaces

Citar esto

Mackasey, M., Egom, E. E., Jansen, H. J., Hua, R., Moghtadaei, M., Liu, Y., Kaur, J., McRae, M. D., Bogachev, O., Rafferty, S. A., Ray, G., Kirkby, A. W., & Rose, R. A. (2018). Natriuretic Peptide Receptor-C Protects Against Angiotensin II-Mediated Sinoatrial Node Disease in Mice. JACC: Basic to Translational Science, 3(6), 824-843. https://doi.org/10.1016/j.jacbts.2018.08.004

@article{869e7cfc68e1428cab26b9d6c10469bb,

title = "Natriuretic Peptide Receptor-C Protects Against Angiotensin II-Mediated Sinoatrial Node Disease in Mice",

abstract = " Sinoatrial node (SAN) disease mechanisms are poorly understood, and therapeutic options are limited. Natriuretic peptide(s) (NP) are cardioprotective hormones whose effects can be mediated partly by the NP receptor C (NPR-C). We investigated the role of NPR-C in angiotensin II (Ang II)-mediated SAN disease in mice. Ang II caused SAN disease due to impaired electrical activity in SAN myocytes and increased SAN fibrosis. Strikingly, Ang II treatment in NPR-C −/− mice worsened SAN disease, whereas co-treatment of wild-type mice with Ang II and a selective NPR-C agonist (cANF) prevented SAN dysfunction. NPR-C may represent a new target to protect against the development of Ang II-induced SAN disease. ",

author = "Martin Mackasey and Egom, {Emmanuel E.} and Jansen, {Hailey J.} and Rui Hua and Motahareh Moghtadaei and Yingjie Liu and Jaspreet Kaur and McRae, {Megan D.} and Oleg Bogachev and Rafferty, {Sara A.} and Gibanananda Ray and Kirkby, {Adam W.} and Rose, {Robert A.}",

note = "Funding Information: Supported by Canadian Institutes of Health Research grants MOP 93718 and 142486 to Prof. Rose. Prof. Rose holds a New Investigator Award from the Heart and Stroke Foundation of Canada. Dr. Egom is an employee of ECTRS Ltd. Mr. Mackasey is the recipient of a Libin Cardiovascular Institute of Alberta graduate scholarship. Dr. Egom held a Heart and Stroke Foundation of Canada fellowship. Dr. Jansen holds a Killam postdoctoral fellowship. Dr. Liu is the recipient of a Cumming School of Medicine postdoctoral scholarship. The other authors have reported that they have no industry relationships relevant to the contents of this paper to disclose. Dr. Egom is currently affiliated with the Department of Medicine, St. Martha{\textquoteright}s Regional Hospital, Antigonish, Nova Scotia, Canada. Publisher Copyright: {\textcopyright} 2018 The Authors",

year = "2018",

month = dec,

doi = "10.1016/j.jacbts.2018.08.004",

language = "English",

volume = "3",

pages = "824--843",

journal = "JACC: Basic to Translational Science",

issn = "2452-302X",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Natriuretic Peptide Receptor-C Protects Against Angiotensin II-Mediated Sinoatrial Node Disease in Mice

AU - Mackasey, Martin

AU - Egom, Emmanuel E.

AU - Jansen, Hailey J.

AU - Hua, Rui

AU - Moghtadaei, Motahareh

AU - Liu, Yingjie

AU - Kaur, Jaspreet

AU - McRae, Megan D.

AU - Bogachev, Oleg

AU - Rafferty, Sara A.

AU - Ray, Gibanananda

AU - Kirkby, Adam W.

AU - Rose, Robert A.

N1 - Funding Information: Supported by Canadian Institutes of Health Research grants MOP 93718 and 142486 to Prof. Rose. Prof. Rose holds a New Investigator Award from the Heart and Stroke Foundation of Canada. Dr. Egom is an employee of ECTRS Ltd. Mr. Mackasey is the recipient of a Libin Cardiovascular Institute of Alberta graduate scholarship. Dr. Egom held a Heart and Stroke Foundation of Canada fellowship. Dr. Jansen holds a Killam postdoctoral fellowship. Dr. Liu is the recipient of a Cumming School of Medicine postdoctoral scholarship. The other authors have reported that they have no industry relationships relevant to the contents of this paper to disclose. Dr. Egom is currently affiliated with the Department of Medicine, St. Martha’s Regional Hospital, Antigonish, Nova Scotia, Canada. Publisher Copyright: © 2018 The Authors

PY - 2018/12

Y1 - 2018/12

N2 - Sinoatrial node (SAN) disease mechanisms are poorly understood, and therapeutic options are limited. Natriuretic peptide(s) (NP) are cardioprotective hormones whose effects can be mediated partly by the NP receptor C (NPR-C). We investigated the role of NPR-C in angiotensin II (Ang II)-mediated SAN disease in mice. Ang II caused SAN disease due to impaired electrical activity in SAN myocytes and increased SAN fibrosis. Strikingly, Ang II treatment in NPR-C −/− mice worsened SAN disease, whereas co-treatment of wild-type mice with Ang II and a selective NPR-C agonist (cANF) prevented SAN dysfunction. NPR-C may represent a new target to protect against the development of Ang II-induced SAN disease.

AB - Sinoatrial node (SAN) disease mechanisms are poorly understood, and therapeutic options are limited. Natriuretic peptide(s) (NP) are cardioprotective hormones whose effects can be mediated partly by the NP receptor C (NPR-C). We investigated the role of NPR-C in angiotensin II (Ang II)-mediated SAN disease in mice. Ang II caused SAN disease due to impaired electrical activity in SAN myocytes and increased SAN fibrosis. Strikingly, Ang II treatment in NPR-C −/− mice worsened SAN disease, whereas co-treatment of wild-type mice with Ang II and a selective NPR-C agonist (cANF) prevented SAN dysfunction. NPR-C may represent a new target to protect against the development of Ang II-induced SAN disease.

UR - http://www.scopus.com/inward/record.url?scp=85059595696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059595696&partnerID=8YFLogxK

U2 - 10.1016/j.jacbts.2018.08.004

DO - 10.1016/j.jacbts.2018.08.004

M3 - Article

AN - SCOPUS:85059595696

SN - 2452-302X

VL - 3

SP - 824

EP - 843

JO - JACC: Basic to Translational Science

JF - JACC: Basic to Translational Science

IS - 6

ER -

Natriuretic Peptide Receptor-C Protects Against Angiotensin II-Mediated Sinoatrial Node Disease in Mice

Resumen

Nota bibliográfica

ASJC Scopus Subject Areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto